Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox
 


  TBE Incidence in Different Age Groups

Every country reported TBE cases in children, the lowest incidence was found in small children less than three years of age. With increasing age, children showed higher incidences. The highest rate reported in children was in the Khabarovsk region in Russia, where 26% of TBE cases were in children aged 014 years. In Slovenia, children represented 23.5% of all confirmed TBE cases in the period of 1959 to 2000. In Austria, the 7- to 14-year-olds formerly were the age group with the greatest annual incidence of TBE (19% of all cases). At present, however, due to the Austrian vaccination program, and in particular the vaccination campaign in schools, children between 7 and 14 years are among the best protected age groups. In Austria, most cases of TBE now occur in older age groups. In Sweden about 10% of the patients are younger than 15 years.

Austria - a comparison of the TBE cases before and after the start of the national school vaccination campaigns.
Austria - a comparison of the TBE cases before and after the start of the national school vaccination campaigns.

The youngest patient known thus far was three months old; the oldest patient was 83 and died showing signs and symptoms of meningoencephalitis. As for TBE prevalence in the different age brackets, an increase with advancing age has been observed in TBE focal areas, although the prevalence in different endemic areas may vary.

 » Printversion

 
 
  » find


 

Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine
» read more

Baxter to participate in development of cell-based vaccines for U.S. Department of Health and Human Services
» read more

Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,